<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": Research Article : Medicine and Health Sciences : Tropical" exact="Diseases" post=": Neglected Tropical Diseases: Chikungunya Infection : Medicine and"/>
 <result pre="Health Sciences : Tropical Diseases : Neglected Tropical Diseases: Chikungunya" exact="Infection" post=": Medicine and Health Sciences : Infectious Diseases :"/>
 <result pre="Tropical Diseases: Chikungunya Infection : Medicine and Health Sciences :" exact="Infectious" post="Diseases : Viral Diseases: Chikungunya Infection : Biology and"/>
 <result pre="Diseases: Chikungunya Infection : Medicine and Health Sciences : Infectious" exact="Diseases" post=": Viral Diseases: Chikungunya Infection : Biology and life"/>
 <result pre="Infection : Medicine and Health Sciences : Infectious Diseases :" exact="Viral" post="Diseases: Chikungunya Infection : Biology and life sciences :"/>
 <result pre="and Health Sciences : Infectious Diseases : Viral Diseases: Chikungunya" exact="Infection" post=": Biology and life sciences : Organisms : Viruses"/>
 <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Togaviruses : Alphaviruses: Chikungunya Virus : Medicine"/>
 <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Togaviruses : Alphaviruses: Chikungunya Virus : Biology"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Togaviruses : Alphaviruses: Chikungunya Virus : Medicine"/>
 <result pre="and Health Sciences : Diagnostic Medicine : Signs and Symptoms:" exact="Fevers" post=": Medicine and Health Sciences : Pathology and Laboratory"/>
 <result pre="Sciences : Pathology and Laboratory Medicine : Signs and Symptoms:" exact="Fevers" post=": Medicine and Health Sciences : Diagnostic Medicine :"/>
 <result pre="in the Colombian Caribbean: Latent classes and gender differences in" exact="virus infection" post="A population-based study of Chikungunya symptoms VidalOscar M.ConceptualizationData curationFormal"/>
 <result pre="the Colombian Caribbean: Latent classes and gender differences in virus" exact="infection" post="A population-based study of Chikungunya symptoms VidalOscar M.ConceptualizationData curationFormal"/>
 <result pre="in tropical areas worldwide. CHIKV causes a severe and debilitating" exact="disease" post="with high morbidity. The first Colombian autochthonous case was"/>
 <result pre="relationship between clinical symptomatology and variation in phenotypic response to" exact="CHIKV infection" post="in humans remains limited. We performed a cross sectional"/>
 <result pre="between clinical symptomatology and variation in phenotypic response to CHIKV" exact="infection" post="in humans remains limited. We performed a cross sectional"/>
 <result pre="that most individuals presented fever (94.4%), headache (73.28%) and general" exact="discomfort" post="(59.4%), which are distinct clinical symptoms of a viral"/>
 <result pre="general discomfort (59.4%), which are distinct clinical symptoms of a" exact="viral infection." post="Furthermore, 11/26 (43.2%) of the categorized symptoms were more"/>
 <result pre="of CHIKV infected individuals. Interestingly, 282 (24.3%) individuals exhibited a" exact="lower" post="symptomatic &quot;extreme�? phenotype and 74 (6.4%) patients were within"/>
 <result pre="CHIKV infected individuals. Interestingly, 282 (24.3%) individuals exhibited a lower" exact="symptomatic" post="&quot;extreme�? phenotype and 74 (6.4%) patients were within the"/>
 <result pre="that can be correlated with differential phenotypic response and perhaps" exact="susceptibility to" post="CHIKV infection, especially in the female population. This suggests"/>
 <result pre="be correlated with differential phenotypic response and perhaps susceptibility to" exact="CHIKV infection," post="especially in the female population. This suggests that, comparatively"/>
 <result pre="response and perhaps susceptibility to CHIKV infection, especially in the" exact="female" post="population. This suggests that, comparatively to men, women are"/>
 <result pre="contribute to the development of machine learning approaches to characterizing" exact="CHIKV infection" post="in other populations. Preliminary results have shown prediction models"/>
 <result pre="to the development of machine learning approaches to characterizing CHIKV" exact="infection" post="in other populations. Preliminary results have shown prediction models"/>
 <result pre="values per LCCA-derived cluster. Author summary The Chikungunya virus (CHIKV)" exact="infection" post="is a mosquito-borne virus of the Togaviridae family, part"/>
 <result pre="group of mosquito-transmitted pathogens. CHIKV causes a severe and debilitating" exact="disease" post="with high morbidity. In this study, we comprehensively analysed"/>
 <result pre="1160 individuals from the Colombian Caribbean, who were diagnosed with" exact="CHIKV infection" post="during the 2014 epidemic peak and before the Zika"/>
 <result pre="individuals from the Colombian Caribbean, who were diagnosed with CHIKV" exact="infection" post="during the 2014 epidemic peak and before the Zika"/>
 <result pre="classes and predictors of CHIKV susceptibility and severity of the" exact="CHIKV infection" post="were analysed. Although it is well known that people"/>
 <result pre="and predictors of CHIKV susceptibility and severity of the CHIKV" exact="infection" post="were analysed. Although it is well known that people"/>
 <result pre="predictors and outlining strategies to study the natural history of" exact="CHIKV infection." post="Future studies assessing the contribution of demographic, immunological and"/>
 <result pre="contribute to the development of machine learning approaches to characterizing" exact="CHIKV infection" post="in other populations and provide more accurate and differential"/>
 <result pre="to the development of machine learning approaches to characterizing CHIKV" exact="infection" post="in other populations and provide more accurate and differential"/>
 <result pre="Martin at the end of 2013.[2] The Asian and Eastern/Central/Southern" exact="African" post="CHIKV strains were the agents causing the epidemic outbreak.[3]"/>
 <result pre="incubation period may last between 3 to 7 days. After" exact="viral" post="inoculation by the mosquito, the virus replicates in the"/>
 <result pre="via the blood stream, to the liver and joints.[9] This" exact="acute" post="phase lasts between 1–12 days reaching viral loads of"/>
 <result pre="and joints.[9] This acute phase lasts between 1–12 days reaching" exact="viral" post="loads of 105−1012 RNA copies per milliliter of blood.[9,10]"/>
 <result pre="RNA copies per milliliter of blood.[9,10] Several studies reported variable" exact="chikungunya" post="symptomatology, i.e., La Reunion outbreak in 2004 showed patients"/>
 <result pre="i.e., La Reunion outbreak in 2004 showed patients with asymmetrical" exact="bilateral" post="polyarthralgia (96%) of the lower (98%) and small joints"/>
 <result pre="2004 showed patients with asymmetrical bilateral polyarthralgia (96%) of the" exact="lower" post="(98%) and small joints (75%), asthenia (89%), headache (70%)"/>
 <result pre="polyarthralgia (96%) of the lower (98%) and small joints (75%)," exact="asthenia" post="(89%), headache (70%) myalgia (59%) and adenopathy (9%).[3,11] The"/>
 <result pre="affected whose clinical manifestations included joint pain, headache, abdominal pain," exact="joint swelling," post="vomiting, rash, and cough.[12] Ray et al. (2012) reported"/>
 <result pre="in other epidemics, such as diarrhea, rhinitis, conjunctival congestion, hepatomegaly," exact="splenomegaly" post="and lymphadenopathy were rarely observed in the India outbreak.[13,14]"/>
 <result pre="lymphadenopathy were rarely observed in the India outbreak.[13,14] Comparison of" exact="acute" post="clinical symptoms between CHIKV outbreaks in La Reunion, India,"/>
 <result pre="with polyarthritis/arthralgia, such as: Sindbis-group viruses, Scandinavian Ockelbo virus, the" exact="African" post="O’nyong-nyong virus (ONN), the South American Mayaro virus (MAY),"/>
 <result pre="Scandinavian Ockelbo virus, the African O’nyong-nyong virus (ONN), the South" exact="American" post="Mayaro virus (MAY), the Australian Barmah Forest virus (BFV),"/>
 <result pre="Samoa in 1979 [21,22]. Epidemiology reports show fluctuating typical and" exact="atypical" post="symptoms from one epidemic to another, possibly due to:"/>
 <result pre="genetic and immunological makeup of the infected population, iii) the" exact="viral" post="strain and iv) the specific applied epidemiological models. This"/>
 <result pre="for and importance of a rigorous clinical profile of the" exact="CHIKV infection" post="in humans.[8,23,24] In this study, we comprehensively analyzed clinical"/>
 <result pre="and importance of a rigorous clinical profile of the CHIKV" exact="infection" post="in humans.[8,23,24] In this study, we comprehensively analyzed clinical"/>
 <result pre="located on the northern Caribbean coast. Patients were diagnosed with" exact="CHIKV infection" post="to evaluate the presence of group of individuals clustering"/>
 <result pre="on the northern Caribbean coast. Patients were diagnosed with CHIKV" exact="infection" post="to evaluate the presence of group of individuals clustering"/>
 <result pre="individuals clustering similar and unique phenotypes (latent classes), predictors of" exact="infection" post="susceptibility, and differential phenotypic response, i.e., a set of"/>
 <result pre="of specific symptoms that an individual generates in response to" exact="CHIKV infection." post="We found strong evidence for the existence of different"/>
 <result pre="offer information about the characteristics of at-risk populations affected by" exact="CHIKV infection" post="and the presence of different subpopulations of phenotypic response."/>
 <result pre="information about the characteristics of at-risk populations affected by CHIKV" exact="infection" post="and the presence of different subpopulations of phenotypic response."/>
 <result pre="point for the development of machine learning approaches to characterizing" exact="CHIKV infection" post="in other populations, in order to provide more accurate"/>
 <result pre="for the development of machine learning approaches to characterizing CHIKV" exact="infection" post="in other populations, in order to provide more accurate"/>
 <result pre="This program is responsible for surveying and reporting outbreaks of" exact="infectious diseases" post="occurring in this geographical area of the Colombian Caribbean"/>
 <result pre="technicians who were responsible for gathering information about the CHIKV" exact="infectious disease" post="emergency and carrying out case and contact investigations, in"/>
 <result pre="who were responsible for gathering information about the CHIKV infectious" exact="disease" post="emergency and carrying out case and contact investigations, in"/>
 <result pre="outbreak. The team collected information about suspected cases, possible contacts," exact="disease" post="characteristics, clinical characteristics, and possible disease exposure, in order"/>
 <result pre="suspected cases, possible contacts, disease characteristics, clinical characteristics, and possible" exact="disease" post="exposure, in order to obtain, prioritize, and submit specimens"/>
 <result pre="submit specimens for laboratory testing. Recruited CHIKV patients were in" exact="acute" post="phases of the infection. We actively collaborated with the"/>
 <result pre="amendments. Subjects and case definition Only clinically confirmed cases of" exact="CHIKV infection" post="were included in this study. Diagnosis was assessed according"/>
 <result pre="Subjects and case definition Only clinically confirmed cases of CHIKV" exact="infection" post="were included in this study. Diagnosis was assessed according"/>
 <result pre="and symptoms included fever &amp;gt;38°C, severe joint pain or initial" exact="acute" post="arthritis symptoms and rash, which could not attributed to"/>
 <result pre="symptoms included fever &amp;gt;38°C, severe joint pain or initial acute" exact="arthritis" post="symptoms and rash, which could not attributed to other"/>
 <result pre="could not attributed to other medical conditions (and after discarding" exact="Dengue" post="virus (DV) infection; S1 Table). Suspected cases were defined"/>
 <result pre="and symptoms included fever &amp;gt;38°C, severe joint pain or initial" exact="acute" post="arthritis symptoms and rash, could not be attributed to"/>
 <result pre="symptoms included fever &amp;gt;38°C, severe joint pain or initial acute" exact="arthritis" post="symptoms and rash, could not be attributed to other"/>
 <result pre="were confirmed by laboratory testing using serum-based RT-PCR to detect" exact="viral" post="RNA. Serum was sampled within the first eight days"/>
 <result pre="of symptoms. Patients presenting signs and symptoms characteristic of DV" exact="infection" post="(S1 Table) were laboratory tested for IgM using ELISA."/>
 <result pre="for DV were excluded from this study. Clinical assessment A" exact="total" post="of 1322 individuals were interviewed and their clinical symptomatology"/>
 <result pre="individuals were interviewed and their clinical symptomatology subsequently registered. Since" exact="infection" post="by CHIKV is a public health concern, and due"/>
 <result pre="were registered using a binary-based system assessing the presence or" exact="absence of" post="26 clinical symptoms in all patients of our cohort"/>
 <result pre="automatically implemented in Latent GOLD was used. Results Participants A" exact="total" post="of 1322 subjects, who attended consultation at health providers,"/>
 <result pre="attended consultation at health providers, and were clinically diagnosed with" exact="CHIKV infection" post="during the main CHIKV outbreak in the Caribbean region,"/>
 <result pre="consultation at health providers, and were clinically diagnosed with CHIKV" exact="infection" post="during the main CHIKV outbreak in the Caribbean region,"/>
 <result pre="the Caribbean region, were included in this study. Due to" exact="incomplete" post="or missing data collection, 162 cases (12%) were excluded."/>
 <result pre="were fever (present in 94% of patients), headache (73%), general" exact="discomfort" post="(59%), neck (54%) and back pain (53%), maculopapular rash"/>
 <result pre="(54%) and back pain (53%), maculopapular rash (51%), myalgia (38%)," exact="arthritis" post="(29%), conjunctivitis (7%), and nausea/vomiting (24%/21%) (Table 2). Some"/>
 <result pre="back pain (53%), maculopapular rash (51%), myalgia (38%), arthritis (29%)," exact="conjunctivitis" post="(7%), and nausea/vomiting (24%/21%) (Table 2). Some patients manifested"/>
 <result pre="(%) χ2(df) P Gender Male 412 (35.52) 97.32 (1) &amp;lt;0.0001" exact="Female" post="748 (64.48) Age group 358.36 (3) &amp;lt;0.0001 Children (&amp;lt;15)"/>
 <result pre="Female(n = 748; %) Male(n = 412; %) χ2 Pa" exact="Fever" post="1095 (94.4) 705 (94.25) 390 (94.66) 0.024 0.852 Dizziness"/>
 <result pre="Ganglia Retroauricular 88 (7.59) 70 (9.36) 18 (4.37) 8.735 0.002*" exact="Submandibular" post="66 (5.69) 55 (7.35) 11 (2.67) 10.003 0.002* Cervical"/>
 <result pre="0.009* Inguinal 65 (5.6) 52 (6.95) 13 (3.16) 6.539 0.009*" exact="General" post="discomfort 689 (59.4) 451 (60.29) 238 (57.77) 0.603 0.356"/>
 <result pre="Inguinal 65 (5.6) 52 (6.95) 13 (3.16) 6.539 0.009* General" exact="discomfort" post="689 (59.4) 451 (60.29) 238 (57.77) 0.603 0.356 Nausea"/>
 <result pre="n = 1,095), headache (73.28%, n = 850) and general" exact="discomfort" post="(59.4%, n = 689) were the most frequent, while"/>
 <result pre="of dizziness (30.2% women vs. 25% men; P = 0.045)," exact="conjunctivitis" post="(9% women vs. 4.6% men; P = 0.011), localized"/>
 <result pre="0.045), conjunctivitis (9% women vs. 4.6% men; P = 0.011)," exact="localized" post="adenopathy (retroauricular, submandibular, axillary; P&amp;lt;0.05), nausea (26.7% women vs."/>
 <result pre="0.012), vomiting (23.8% women vs. 16.8% men; P = 0.002)," exact="and neck" post="(57.1% women vs. 49.8% men; P = 0.034) and"/>
 <result pre="Adynamia, S4: Conjunctivitis, S5: Arthralgia, S6: Difficulty grasping, S7: Retro" exact="auricular" post="ganglia, S8: Submandibular ganglia, S9: Cervical ganglia, S10: Axillary"/>
 <result pre="S5: Arthralgia, S6: Difficulty grasping, S7: Retro auricular ganglia, S8:" exact="Submandibular" post="ganglia, S9: Cervical ganglia, S10: Axillary ganglia, S11: Inguinal"/>
 <result pre="S9: Cervical ganglia, S10: Axillary ganglia, S11: Inguinal ganglia, S12:" exact="General" post="discomfort, S13: Nausea, S14: Cough, S15: Headache, S16: Vomiting,"/>
 <result pre="profiles, suggesting the existence of distinct subpopulations within patients with" exact="CHIKV infection" post="(Fig 3 and Table 3). Of the 1061 patients,"/>
 <result pre="suggesting the existence of distinct subpopulations within patients with CHIKV" exact="infection" post="(Fig 3 and Table 3). Of the 1061 patients,"/>
 <result pre="2. 10.1371/journal.pntd.0008281.t003Table 3 Summary of LCCA-derived clusters in individuals with" exact="CHIKV infection." post="Clinical Symptom Cluster 1 Cluster 2 Cluster 3 Cluster"/>
 <result pre="205 (17.7) 128 (11) 118 (10.2) 97 (8.4) 74 (6.4)" exact="Fever" post="256 (90.8) 249 (97.3) 187 (91.2) 127 (99.2) 110"/>
 <result pre="8 (3.9) 14 (10.9) 1 (0.8) 3 (3.1) 54 (73.6)" exact="Submandibular" post="0 (0) 0 (0) 6 (2.9) 9 (7) 3"/>
 <result pre="16 (7.8) 2 (1.6) 3 (2.5) 7 (7.2) 37 (50)" exact="General" post="discomfort 140 (49.6) 174 (68) 70 (34.2) 102 (79.7)"/>
 <result pre="(7.8) 2 (1.6) 3 (2.5) 7 (7.2) 37 (50) General" exact="discomfort" post="140 (49.6) 174 (68) 70 (34.2) 102 (79.7) 38"/>
 <result pre="(45.9) 80 (62.5) 96 (81.4) 0 (0) 34 (45.8) Sex" exact="Female" post="166 (58.8) 163 (63.7) 146 (71) 92 (71.9) 70"/>
 <result pre="17.7%) who are more likely to experience fever, cough, headache," exact="and neck" post="and back pain, while Cluster 4 (n = 128,"/>
 <result pre="response as they deviate from the natural history of the" exact="disease" post="(Figs 3 and 4), and confirm the divergence of"/>
 <result pre="jointly associated with a differential phenotypic response in individuals with" exact="CHIKV infection." post="Closer inspection of the characteristics of the LCCA-derived clusters"/>
 <result pre="in clusters 4 and 7, particularly in the AYA and" exact="adult" post="groups, although the extreme patterns of phenotypic response occur"/>
 <result pre="Thus, this could potentially be used for defining extreme and" exact="intermediate" post="phenotypes of CHIKV infection. Furthermore, the fact that i)"/>
 <result pre="potentially be used for defining extreme and intermediate phenotypes of" exact="CHIKV infection." post="Furthermore, the fact that i) females show distinct phenotypic"/>
 <result pre="importance of gender-specific and phenotypic-response-specific treatments focused on the at-risk" exact="female" post="CHIKV population, and subpopulations with a more extreme phenotypic"/>
 <result pre="phenotypic response to the infection. Sex dimorphic immune response towards" exact="viral infection" post="is commonly described in the literature.[33] For example, it"/>
 <result pre="response to the infection. Sex dimorphic immune response towards viral" exact="infection" post="is commonly described in the literature.[33] For example, it"/>
 <result pre="of higher levels of Interferon alpha (INFα) in response to" exact="viral" post="pathogens.[33,34] Furthermore, sex dimorphic immune response to viral infections"/>
 <result pre="response to viral pathogens.[33,34] Furthermore, sex dimorphic immune response to" exact="viral" post="infections has shown higher intensity (i.e. viral load within"/>
 <result pre="to viral pathogens.[33,34] Furthermore, sex dimorphic immune response to viral" exact="infections" post="has shown higher intensity (i.e. viral load within an"/>
 <result pre="immune response to viral infections has shown higher intensity (i.e." exact="viral" post="load within an individual) and prevalence (i.e. number of"/>
 <result pre="population) in males, while females can have a more favorable" exact="disease" post="outcome.[35] Females have a stronger immune response relative to"/>
 <result pre="immune response relative to males, which can result in faster" exact="viral" post="clearance. In vitro experiments have shown that cells from"/>
 <result pre="to the development of autoimmunological disorders in females, such as," exact="systemic" post="lupus erythematosus, Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid"/>
 <result pre="the development of autoimmunological disorders in females, such as, systemic" exact="lupus erythematosus," post="Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis and"/>
 <result pre="females, such as, systemic lupus erythematosus, Graves’ disease, Hashimoto’s thyroiditis," exact="multiple sclerosis," post="rheumatoid arthritis and scleroderma.[36] A stronger female immune response"/>
 <result pre="as, systemic lupus erythematosus, Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis," exact="rheumatoid arthritis" post="and scleroderma.[36] A stronger female immune response towards CHIKV"/>
 <result pre="systemic lupus erythematosus, Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid" exact="arthritis" post="and scleroderma.[36] A stronger female immune response towards CHIKV"/>
 <result pre="Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis and scleroderma.[36] A stronger" exact="female" post="immune response towards CHIKV infection may be associated with"/>
 <result pre="rheumatoid arthritis and scleroderma.[36] A stronger female immune response towards" exact="CHIKV infection" post="may be associated with a complex symptomatology (fever, dizziness,"/>
 <result pre="arthritis and scleroderma.[36] A stronger female immune response towards CHIKV" exact="infection" post="may be associated with a complex symptomatology (fever, dizziness,"/>
 <result pre="Epidemiological studies have shown that males are more vulnerable to" exact="viral" post="infections as their mortality rate is higher compared to"/>
 <result pre="studies have shown that males are more vulnerable to viral" exact="infections" post="as their mortality rate is higher compared to women,[37]"/>
 <result pre="a stronger immune response is clearly an advantage for certain" exact="viral" post="infections, with CHIKV infection a potential dissemination of viral"/>
 <result pre="response is clearly an advantage for certain viral infections, with" exact="CHIKV infection" post="a potential dissemination of viral particles to lymph nodes,"/>
 <result pre="is clearly an advantage for certain viral infections, with CHIKV" exact="infection" post="a potential dissemination of viral particles to lymph nodes,"/>
 <result pre="certain viral infections, with CHIKV infection a potential dissemination of" exact="viral" post="particles to lymph nodes, joints and other tissues may"/>
 <result pre="men.[39–41] Kam et al. [42] investigated the CHIKV route of" exact="infection" post="starting at epithelial and endothelial cells, primary fibroblasts, monocytes"/>
 <result pre="al. [42] investigated the CHIKV route of infection starting at" exact="epithelial" post="and endothelial cells, primary fibroblasts, monocytes and monocyte-derived macrophages,"/>
 <result pre="CHIKV route of infection starting at epithelial and endothelial cells," exact="primary" post="fibroblasts, monocytes and monocyte-derived macrophages, further disseminating to lymph"/>
 <result pre="to lymph nodes, joints and other tissues.[43] Spread of the" exact="infection" post="to the joints results in arthralgia, which mirrors rheumatoid"/>
 <result pre="the infection to the joints results in arthralgia, which mirrors" exact="rheumatoid arthritis," post="a condition characterized by joint pain as the result"/>
 <result pre="factors that have shown to modulate human response to arbovirus" exact="infection" post="and hence be responsible for the clinical symptomatology differentiation"/>
 <result pre="it to a susceptible host;[45] (ii) the variety of the" exact="viral" post="strain, in which genetic studies have shown that CHIKV"/>
 <result pre="rs3764879 in the TLR-8 gene have been associated with increased" exact="CHIKV infection" post="susceptibility.[47] These SNPs were also found to be associated"/>
 <result pre="in the TLR-8 gene have been associated with increased CHIKV" exact="infection" post="susceptibility.[47] These SNPs were also found to be associated"/>
 <result pre="pain, and rashes.[47] As our study population has a strong" exact="African" post="admixture,[48–50] [51] future studies should focus on determining the"/>
 <result pre="this understudied population. Furthermore, considering that CHIKV originated in the" exact="African" post="continent, genetic ancestry in our population could help to"/>
 <result pre="impacted during arthropod virus outbreaks, such as dengue, an endemic" exact="disease" post="in the city. Although in the present study we"/>
 <result pre="the present study we only included clinically confirmed cases of" exact="CHIKV infection," post="all cases were defined according to the criteria described"/>
 <result pre="1410 laboratory confirmed cases in 2014,[52,53] with estimates of asymptomatic" exact="CHIKV infection" post="varying around ~3–25%.[54] Nevertheless, unlike other arboviruses, the quantity"/>
 <result pre="laboratory confirmed cases in 2014,[52,53] with estimates of asymptomatic CHIKV" exact="infection" post="varying around ~3–25%.[54] Nevertheless, unlike other arboviruses, the quantity"/>
 <result pre="around ~3–25%.[54] Nevertheless, unlike other arboviruses, the quantity of asymptomatic" exact="CHIKV infection" post="patients is low. In addition, experience of the surveillance"/>
 <result pre="~3–25%.[54] Nevertheless, unlike other arboviruses, the quantity of asymptomatic CHIKV" exact="infection" post="patients is low. In addition, experience of the surveillance"/>
 <result pre="potentially help to identify specific symptom patterns more clearly in" exact="CHIKV infection" post="and facilitate patient management. Future studies assessing the contribution"/>
 <result pre="help to identify specific symptom patterns more clearly in CHIKV" exact="infection" post="and facilitate patient management. Future studies assessing the contribution"/>
 <result pre="genetic factors to symptom co-occurrence, and correlating this symptomatology with" exact="viral" post="strain and/or CHIKV genetic variation could shed some light"/>
 <result pre="maximally expanded sample was comprised of 1161 individuals diagnosed with" exact="CHIKV infection" post="based on clinical symptomatology. Of note, individuals were recruited"/>
 <result pre="expanded sample was comprised of 1161 individuals diagnosed with CHIKV" exact="infection" post="based on clinical symptomatology. Of note, individuals were recruited"/>
 <result pre="on clinical symptomatology. Of note, individuals were recruited during the" exact="acute" post="phase of the CHIKV infection. This diagnosis was performed"/>
 <result pre="note, individuals were recruited during the acute phase of the" exact="CHIKV infection." post="This diagnosis was performed following a clinical protocol developed"/>
 <result pre="based on a similar protocol previously applied to diagnosis of" exact="Dengue" post="virus infection (S1 Table). The chikungunya outbreak occurred in"/>
 <result pre="on a similar protocol previously applied to diagnosis of Dengue" exact="virus infection" post="(S1 Table). The chikungunya outbreak occurred in the Colombian"/>
 <result pre="a similar protocol previously applied to diagnosis of Dengue virus" exact="infection" post="(S1 Table). The chikungunya outbreak occurred in the Colombian"/>
 <result pre="applied to diagnosis of Dengue virus infection (S1 Table). The" exact="chikungunya" post="outbreak occurred in the Colombian Caribbean back in 2014/15,"/>
 <result pre="testing using RT-PCR. Interestingly, we found concordance between the clinical-symptomatology-based" exact="CHIKV infection" post="diagnosis and that provided by the laboratory test. All"/>
 <result pre="using RT-PCR. Interestingly, we found concordance between the clinical-symptomatology-based CHIKV" exact="infection" post="diagnosis and that provided by the laboratory test. All"/>
 <result pre="a reliable and easy-to-use method of providing accurate diagnosis of" exact="CHIKV infection" post="in developing and Latin American countries, where budget and"/>
 <result pre="reliable and easy-to-use method of providing accurate diagnosis of CHIKV" exact="infection" post="in developing and Latin American countries, where budget and"/>
 <result pre="providing accurate diagnosis of CHIKV infection in developing and Latin" exact="American" post="countries, where budget and time constraints are increasing, or"/>
 <result pre="outcome data, such as vital signs, duration of symptoms and" exact="disease" post="evolution. Because of this, we were unable to establish"/>
 <result pre="and the profiles of phenotypic response exhibited by individuals with" exact="CHIKV infection" post="(Fig 3 and Fig 4). Although we identified that"/>
 <result pre="the profiles of phenotypic response exhibited by individuals with CHIKV" exact="infection" post="(Fig 3 and Fig 4). Although we identified that"/>
 <result pre="longitudinal nature, to better understand long-term outcomes in individuals with" exact="CHIKV infection" post="exhibiting such patterns of phenotypic response to the virus."/>
 <result pre="nature, to better understand long-term outcomes in individuals with CHIKV" exact="infection" post="exhibiting such patterns of phenotypic response to the virus."/>
 <result pre="approaches to treating this infection. In low-, mid-income and Latin" exact="American" post="countries, the use of these characterizations could enhance the"/>
 <result pre="the development, validation and implementation of alternative ways of diagnosing" exact="CHIKV infection" post="based on clinical symptomatology machine learning (ML) algorithms, to"/>
 <result pre="development, validation and implementation of alternative ways of diagnosing CHIKV" exact="infection" post="based on clinical symptomatology machine learning (ML) algorithms, to"/>
 <result pre="effective, accurate and easy to use in CHIKV,[57] and other" exact="infectious" post="diseases.[58] Preliminary results of the implementation of ML algorithms"/>
 <result pre="additional data file. S1 Table Differential diagnosis between CHIKV and" exact="Dengue" post="virus. (XLSX) LINK Click here for additional data file."/>
 <result pre="to predict differential phenotypic response (i.e., cluster) in individuals with" exact="CHIKV infection" post="using clinical symptomatology. Algorithms were implemented in R. Here,"/>
 <result pre="predict differential phenotypic response (i.e., cluster) in individuals with CHIKV" exact="infection" post="using clinical symptomatology. Algorithms were implemented in R. Here,"/>
 <result pre="Rodriguez-MoralesA.J.; BlohmG.; MarquezM.; Villamil-GomezW.E.ChikDenMaZika Syndrome: the challenge of diagnosing arboviral" exact="infections" post="in the midst of concurrent epidemics. Ann Clin Microbiol"/>
 <result pre="BrunS.; Le GrandR.; GrasG.; RoquesP.Chikungunya disease: infection-associated markers from the" exact="acute" post="to the chronic phase of arbovirus-induced arthralgia. PLoS Negl"/>
 <result pre="GrasG.; RoquesP.Chikungunya disease: infection-associated markers from the acute to the" exact="chronic" post="phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis2012, 6,"/>
 <result pre="PoubeauP.; StaikowskyF.; LoryM.; Le MoullecN.; BecquartJ.P.; WenglingC.; MichaultA.; PaganinF.Outbreak of" exact="chikungunya" post="on Reunion Island: early clinical and laboratory features in"/>
 <result pre="on Reunion Island: early clinical and laboratory features in 157" exact="adult" post="patients. Clin Infect Dis2007, 44, 1401–1407, 10.1086/51753717479933 12ChopraA.; AnuradhaV.;"/>
 <result pre="842–850, 10.1017/S095026881100130021767452 13RayP.; RatagiriV.H.; KabraS.K.; LodhaR.; SharmaS.; SharmaB.S.; KalaivaniM.; WigN.Chikungunya" exact="infection" post="in India: results of a prospective hospital based multi-centric"/>
 <result pre="virus infections: clinical manifestations, mortality and risk factors for severe" exact="disease" post="during the 2005–2006 outbreak on Réunion. Epidemiol Infect2009, 137,"/>
 <result pre="FernandezS.; ThaisomboonsukB.; KlungthongC.; LevyJ.W.; VelascoJ.M., et al.High rate of subclinical" exact="chikungunya" post="virus infection and association of neutralizing antibody with protection"/>
 <result pre="ThaisomboonsukB.; KlungthongC.; LevyJ.W.; VelascoJ.M., et al.High rate of subclinical chikungunya" exact="virus infection" post="and association of neutralizing antibody with protection in a"/>
 <result pre="KlungthongC.; LevyJ.W.; VelascoJ.M., et al.High rate of subclinical chikungunya virus" exact="infection" post="and association of neutralizing antibody with protection in a"/>
 <result pre="GilmoreK.; LidburyB.A.; MahalingamS.Ross River virus: molecular and cellular aspects of" exact="disease" post="pathogenesis. Pharmacol Ther2005, 107, 329–342, 10.1016/j.pharmthera.2005.03.00615923040 17RulliN.E.; MeltonJ.; WilmesA.;"/>
 <result pre="17RulliN.E.; MeltonJ.; WilmesA.; EwartG.; MahalingamS.The molecular and cellular aspects of" exact="arthritis" post="due to alphavirus infections: lesson learned from Ross River"/>
 <result pre="MataikaJ.U.; LawrenceG.W.; RabukawaqaV.; TuckerM.M.; MilesJ.A.; DalglishD.A.An epidemic of Ross River" exact="virus infection" post="in Fiji, 1979. Am J Trop Med Hyg1981, 30,"/>
 <result pre="LawrenceG.W.; RabukawaqaV.; TuckerM.M.; MilesJ.A.; DalglishD.A.An epidemic of Ross River virus" exact="infection" post="in Fiji, 1979. Am J Trop Med Hyg1981, 30,"/>
 <result pre="VillarrealJ.; PereiraG.C.; GodoiL.C.; da FonsecaF.G.Undetected Chikungunya virus co-infections in a" exact="Brazilian" post="region presenting hyper-endemic circulation of Dengue and Zika. J"/>
 <result pre="virus co-infections in a Brazilian region presenting hyper-endemic circulation of" exact="Dengue" post="and Zika. J Clin Virol2019, 113, 27–30, 10.1016/j.jcv.2019.02.00630836281 26DANE."/>
 <result pre="the False Discovery Rate: A Practical and Powerful Approach to" exact="Multiple" post="Testing. Journal of the Royal Statistical Society. Series B"/>
 <result pre="MaryM.; van BelkumA.Semantic data interoperability, digital medicine, and e-health in" exact="infectious disease" post="management: a review. Eur J Clin Microbiol Infect Dis2019,"/>
 <result pre="van BelkumA.Semantic data interoperability, digital medicine, and e-health in infectious" exact="disease" post="management: a review. Eur J Clin Microbiol Infect Dis2019,"/>
 <result pre="Infect Dis2019, 38, 1023–1034, 10.1007/s10096-019-03501-630771124 32JensenS.O.; van HalS.J.Personalized Medicine and" exact="Infectious" post="Disease Management. Trends Microbiol2017, 25, 875–876, 10.1016/j.tim.2017.09.00628969882 33BerghöferB.; FrommerT.;"/>
 <result pre="Dis2019, 38, 1023–1034, 10.1007/s10096-019-03501-630771124 32JensenS.O.; van HalS.J.Personalized Medicine and Infectious" exact="Disease" post="Management. Trends Microbiol2017, 25, 875–876, 10.1016/j.tim.2017.09.00628969882 33BerghöferB.; FrommerT.; HaleyG.;"/>
 <result pre="PerissiE.; CozzolinoF.; GaraciE., et al.Sex differences in the response to" exact="viral" post="infections: TLR8 and TLR9 ligand stimulation induce higher IL10"/>
 <result pre="responses to viruses, and efficacy of prophylaxis and treatments for" exact="viral" post="diseases. Bioessays2012, 34, 1050–1059, 10.1002/bies.20120009923012250 36van LunzenJ.; AltfeldM.Sex differences"/>
 <result pre="diseases. Bioessays2012, 34, 1050–1059, 10.1002/bies.20120009923012250 36van LunzenJ.; AltfeldM.Sex differences in" exact="infectious" post="diseases-common but neglected. J Infect Dis2014, 209Suppl 3, S79–80,"/>
 <result pre="S79–80, 10.1093/infdis/jiu15924966193 37MarriottI.; Huet-HudsonY.M.Sexual dimorphism in innate immune responses to" exact="infectious" post="organisms. Immunol Res2006, 34, 177–192, 10.1385/IR:34:3:17716891670 38GhoshS.; KleinR.S.Sex Drives"/>
 <result pre="34, 177–192, 10.1385/IR:34:3:17716891670 38GhoshS.; KleinR.S.Sex Drives Dimorphic Immune Responses to" exact="Viral" post="Infections. J Immunol2017, 198, 1782–1790, 10.4049/jimmunol.160116628223406 39LarcombeA.N.; FoongR.E.; BozanichE.M.;"/>
 <result pre="JonesJ.E.; DoushaL.F.; ZoskyG.R.; SlyP.D.Sexual dimorphism in lung function responses to" exact="acute" post="influenza A infection. Influenza Other Respir Viruses2011, 5, 334–342,"/>
 <result pre="42KamY.W.; OngE.K.; RéniaL.; TongJ.C.; NgL.F.Immuno-biology of Chikungunya and implications for" exact="disease" post="intervention. Microbes Infect2009, 11, 1186–1196, 10.1016/j.micinf.2009.09.00319737625 43HerZ.; MalleretB.; ChanM.;"/>
 <result pre="ChanM.; OngE.K.; WongS.C.; KwekD.J.; TolouH.; LinR.T.; TambyahP.A.; RéniaL., et al.Active" exact="infection" post="of human blood monocytes by Chikungunya virus triggers an"/>
 <result pre="10.1111/j.1365-2249.2007.03441.x17590166 45AmdekarS.; ParasharD.; AlagarasuK.Chikungunya Virus-Induced Arthritis: Role of Host and" exact="Viral" post="Factors in the Pathogenesis. Viral Immunol2017, 30, 691–702, 10.1089/vim.2017.005228910194"/>
 <result pre="Arthritis: Role of Host and Viral Factors in the Pathogenesis." exact="Viral" post="Immunol2017, 30, 691–702, 10.1089/vim.2017.005228910194 46LanciottiR.S.; LambertA.J.Phylogenetic Analysis of Chikungunya"/>
 <result pre="94, 800–803, 10.4269/ajtmh.15-037526856917 47DuttaS.K.; TripathiA.Association of toll-like receptor polymorphisms with" exact="susceptibility to" post="chikungunya virus infection. Virology2017, 511, 207–213, 10.1016/j.virol.2017.08.00928888110 48Barragán-Duarte, J.L."/>
 <result pre="10.4269/ajtmh.15-037526856917 47DuttaS.K.; TripathiA.Association of toll-like receptor polymorphisms with susceptibility to" exact="chikungunya" post="virus infection. Virology2017, 511, 207–213, 10.1016/j.virol.2017.08.00928888110 48Barragán-Duarte, J.L. Mapa"/>
 <result pre="47DuttaS.K.; TripathiA.Association of toll-like receptor polymorphisms with susceptibility to chikungunya" exact="virus infection." post="Virology2017, 511, 207–213, 10.1016/j.virol.2017.08.00928888110 48Barragán-Duarte, J.L. Mapa genético de"/>
 <result pre="54StaplesJ.E.; BreimanR.F.; PowersA.M.Chikungunya fever: an epidemiological review of a re-emerging" exact="infectious disease." post="Clin Infect Dis2009, 49, 942–948, 10.1086/60549619663604 55Shahadat HossainM.; SultanaZ.;"/>
 <result pre="10, 37–54. 56Caicedo-TorresW.; Paternina-Caicedo�?.; Pinzón-RedondoH.; J., G. Differential Diagnosis of" exact="Dengue" post="and Chikungunya in Colombian Children Using Machine Learning In"/>
 <result pre="2018; Vol. 11238. 57T., B.; P., S. Machine Learning Toward" exact="Infectious" post="Disease Treatment. In Machine Intelligence and Signal AnalysisAdvances in"/>
 <result pre="Vol. 11238. 57T., B.; P., S. Machine Learning Toward Infectious" exact="Disease" post="Treatment. In Machine Intelligence and Signal AnalysisAdvances in Intelligent"/>
 <result pre="PachoriR., Eds. Springer: Singapore, 2019; Vol. 748. 58ChaeS.; KwonS.; LeeD.Predicting" exact="Infectious" post="Disease Using Deep Learning and Big Data. Int J"/>
 <result pre="Eds. Springer: Singapore, 2019; Vol. 748. 58ChaeS.; KwonS.; LeeD.Predicting Infectious" exact="Disease" post="Using Deep Learning and Big Data. Int J Environ"/>
</results>
